Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections

被引:66
作者
Burnham, Jason P. [1 ]
Olsen, Margaret A. [1 ]
Stwalley, Dustin [1 ]
Kwon, Jennie H. [1 ]
Babcock, Hilary M. [1 ]
Kollef, Marin H. [2 ]
机构
[1] Washington Univ, Sch Med, Div Infect Dis, 4523 Clayton Ave,Campus Box 8051, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
infectious diseases consultation; multidrug-resistant organisms; STAPHYLOCOCCUS-AUREUS BACTEREMIA; IMPACT; CARE; PREDICTORS; OUTCOMES;
D O I
10.1093/ofid/ofy026
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Multidrug-resistant organism (MDRO) infections are associated with high mortality and readmission rates. Infectious diseases (ID) consultation improves clinical outcomes for drug-resistant Staphylococcus aureus bloodstream infections. Our goal was to determine the association between ID consultation and mortality following various MDRO infections. Methods. This study was conducted with a retrospective cohort (January 1, 2006-October 1, 2015) at an academic tertiary referral center. We identified patients with MDROs in a sterile site or bronchoalveolar lavage/bronchial wash culture. Mortality and readmissions within 1 year of index culture were identified, and the association of ID consultation with these outcomes was determined using Cox proportional hazards models with inverse weighting by the propensity score for ID consultation. Results. A total of 4214 patients with MDRO infections were identified. ID consultation was significantly associated with reductions in 30-day and 1-year mortality for resistant S. aureus (hazard ratio [HR], 0.48; 95% confidence interval [CI], 0.36-0.63; and HR, 0.73, 95% CI, 0.61-0.86) and Enterobacteriaceae (HR, 0.41; 95% CI, 0.27-0.64; and HR, 0.74; 95% CI, 0.59-0.94), and 30-day mortality for polymicrobial infections (HR, 0.51; 95% CI, 0.31-0.86) but not Acinetobacter or Pseudomonas. For resistant Enterococcus, ID consultation was marginally associated with decreased 30-day mortality (HR, 0.81; 95% CI, 0.62-1.06). ID consultation was associated with reduced 30-day readmission for resistant Enterobacteriaceae. Conclusions. ID consultation was associated with significant reductions in 30-day and 1-year mortality for resistant S. aureus and Enterobacteriaceae, and 30-day mortality for polymicrobial infections. There was no association between ID consultation and mortality for patients with resistant Pseudomonas, Acinetobacter, or Enterococcus, possibly due to small sample sizes. Our results suggest that ID consultation may be beneficial for patients with some MDRO infections.
引用
收藏
页数:5
相关论文
共 28 条
[11]   Using claims data to predict dependency in activities of daily living as a proxy for frailty [J].
Faurot, Keturah R. ;
Funk, Michele Jonsson ;
Pate, Virginia ;
Brookhart, M. Alan ;
Patrick, Amanda ;
Hanson, Laura C. ;
Castillo, Wendy Camelo ;
Stuermer, Til .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (01) :59-66
[12]   A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy? [J].
Guillamet, Cristina Vazquez ;
Vazquez, Rodrigo ;
Noe, Jonas ;
Micek, Scott T. ;
Kollef, Marin H. .
MEDICINE, 2016, 95 (35)
[13]   Impact of Infectious Disease Consultation on the Clinical and Economic Outcomes of Solid Organ Transplant Recipients Admitted for Infectious Complications [J].
Hamandi, Bassem ;
Husain, Shahid ;
Humar, Atul ;
Papadimitropoulos, Emmanuel A. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (08) :1074-1082
[14]   Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant Gram-negative bacteria [J].
Kollef, Katherhie E. ;
Schramm, Garrett E. ;
Wills, Angela R. ;
Reichley, Richard M. ;
Micek, Scott T. ;
Kollef, Marin H. .
CHEST, 2008, 134 (02) :281-287
[15]   Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children [J].
Liu, Catherine ;
Bayer, Arnold ;
Cosgrove, Sara E. ;
Daum, Robert S. ;
Fridkin, Scott K. ;
Gorwitz, Rachel J. ;
Kaplan, Sheldon L. ;
Karchmer, Adolf W. ;
Levine, Donald P. ;
Murray, Barbara E. ;
Rybak, Michael J. ;
Talan, David A. ;
Chambers, Henry F. .
CLINICAL INFECTIOUS DISEASES, 2011, 52 (03) :E18-E55
[16]   Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance [J].
Magiorakos, A. -P. ;
Srinivasan, A. ;
Carey, R. B. ;
Carmeli, Y. ;
Falagas, M. E. ;
Giske, C. G. ;
Harbarth, S. ;
Hindler, J. F. ;
Kahlmeter, G. ;
Olsson-Liljequist, B. ;
Paterson, D. L. ;
Rice, L. B. ;
Stelling, J. ;
Struelens, M. J. ;
Vatopoulos, A. ;
Weber, J. T. ;
Monnet, D. L. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (03) :268-281
[17]   An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance [J].
Micek, Scott T. ;
Wunderink, Richard G. ;
Kollef, Marin H. ;
Chen, Catherine ;
Rello, Jordi ;
Chastre, Jean ;
Antonelli, Massimo ;
Welte, Tobias ;
Clair, Bernard ;
Ostermann, Helmut ;
Calbo, Esther ;
Torres, Antoni ;
Menichetti, Francesco ;
Schramm, Garrett E. ;
Menon, Vandana .
CRITICAL CARE, 2015, 19
[18]   Pseudomonas aeruginosa bloodstream infection:: Importance of appropriate initial antimicrobial treatment [J].
Micek, ST ;
Lloyd, AE ;
Ritchie, DJ ;
Reichley, RM ;
Fraser, VJ ;
Kollef, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) :1306-1311
[19]   Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis [J].
Nathwani, Dilip ;
Raman, Gowri ;
Sulham, Katherine ;
Gavaghan, Meghan ;
Menon, Vandana .
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2014, 3
[20]   The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida [J].
Safdar, N ;
Maki, DG .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (11) :834-844